Category: Steris Corp.Syndicate content

EPA advisory panel's ruling could disrupt medtech

November 18, 2014 by Brad Perriello

An EPA advisory panel meeting that began today could disrupt medical device supply chains if the panel upholds the agency's classification of a ubiquitous sterilizer as carcinogenic.

EPA advisory panel's ruling could disrupt medtech

A scientific advisory panel to the EPA is convening today to evalute the environmental watchdog's determination that a common medical device sterilizer, ethylene oxide, is carcinogenic.

If the panel confirms that assessment, medtech companies warn, it could disrupt the supply chain for their lifesaving products.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Contract sterilization company Sterigenics up for sale: sources

October 23, 2014 by MassDevice

Sterigenics is put on the auction block by its private equity owners, who hope the contract sterilization company will fetch $1.5 billion.

Contract sterilization company Sterigenics up for sale: sources

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic reveals leadership team after mega-merger with Covidien | The week in medtech M&A

October 15, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic announces leadership roster for post-Covidien merger; Allergan raises outlook; says Valeant offer undervalues company; EuroZone anti-trust regulators to rule next month on $43B Covidien buy; Steris to buy UK's Synergy Health, tax savings eyed; Bioventus bolsters bone healing lineup

Medtronic announces leadership roster for post-Covidien merger

October 10, 2014 by Brad Perriello

Steris to buy UK's Synergy Health, tax savings eyed

October 14, 2014 by MassDevice

Steris agrees to a $1.9 billion buyout of U.K. sterilization services provider Synergy Health in the 1st inversion deal since a U.S. Treasury crackdown.

Steris to buy UK's Synergy Health, tax savings eyed

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic-Covidien merger may get caught in anti-inversion legislation | Medtech legal news for the week of July 21, 2014

July 21, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Medtronic fights tax dodging rhetoric in Covidien merger; Travelers holds out on BD's $67M coverage claim; Abbott CEO defends inversions amid corporate exodus furor; Steris, Medtrica win legal fees in Cygnus Medical patent spat;

Could Medtronic-Covidien deal get caught in anti-inversion legislation?

July 16, 2014 by Arezu Sarvestani

Could Medtronic-Covidien deal get caught in anti-inversion legislation?

Steris, Medtrica win legal fees in Cygnus Medical patent spat

July 15, 2014 by Brad Perriello

A federal judge agrees to award legal fees to Steris and Medtrica in their patent infringement win over Cygnus Medical, after a U.S. Supreme court decision reboots the rules on awarding legal costs.

Steris, Medtrica win legal fees in Cygnus Medical patent spat

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA warns Steris Isomedix on QA, data manipulation issues

June 4, 2014 by Arezu Sarvestani

FDA inspectors identify a handful of violations at Steris Isomedix's sterilization facility, including concerns that the company failed to respond appropriately to incidents in which employees were manipulating data.

FDA warns Steris Isomedix on QA issues

Steris's (NYSE:STE) Isomedix division is in the FDA's hotseat after inspectors turned up incidents in which employees faked data on testing for medical devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp